1. Home
  2. GBIO vs BANL Comparison

GBIO vs BANL Comparison

Compare GBIO & BANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • BANL
  • Stock Information
  • Founded
  • GBIO 2016
  • BANL 2015
  • Country
  • GBIO United States
  • BANL Malaysia
  • Employees
  • GBIO N/A
  • BANL N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • BANL Oil Refining/Marketing
  • Sector
  • GBIO Health Care
  • BANL Energy
  • Exchange
  • GBIO Nasdaq
  • BANL Nasdaq
  • Market Cap
  • GBIO 29.2M
  • BANL 25.3M
  • IPO Year
  • GBIO 2020
  • BANL 2023
  • Fundamental
  • Price
  • GBIO $0.38
  • BANL $0.73
  • Analyst Decision
  • GBIO Strong Buy
  • BANL
  • Analyst Count
  • GBIO 4
  • BANL 0
  • Target Price
  • GBIO $7.33
  • BANL N/A
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • BANL 638.7K
  • Earning Date
  • GBIO 08-06-2025
  • BANL 04-16-2025
  • Dividend Yield
  • GBIO N/A
  • BANL N/A
  • EPS Growth
  • GBIO N/A
  • BANL N/A
  • EPS
  • GBIO N/A
  • BANL N/A
  • Revenue
  • GBIO $24,556,000.00
  • BANL $592,517,545.00
  • Revenue This Year
  • GBIO N/A
  • BANL N/A
  • Revenue Next Year
  • GBIO N/A
  • BANL N/A
  • P/E Ratio
  • GBIO N/A
  • BANL N/A
  • Revenue Growth
  • GBIO 146.47
  • BANL 35.93
  • 52 Week Low
  • GBIO $0.30
  • BANL $0.55
  • 52 Week High
  • GBIO $3.65
  • BANL $1.35
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 53.33
  • BANL 41.99
  • Support Level
  • GBIO $0.32
  • BANL $0.73
  • Resistance Level
  • GBIO $0.36
  • BANL $1.03
  • Average True Range (ATR)
  • GBIO 0.03
  • BANL 0.08
  • MACD
  • GBIO 0.00
  • BANL -0.01
  • Stochastic Oscillator
  • GBIO 87.78
  • BANL 10.79

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

Share on Social Networks: